ROCO
6569
Market cap110mUSD
Jul 09, Last price
106.50TWD
1D
0.95%
1Q
5.97%
Jan 2017
-3.95%
IPO
-3.95%
Name
Onyx Healthcare Inc
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Onyx Healthcare Inc. is a dedicated Taiwanese firm specializing in medical information technology. The company focuses on the entire lifecycle—from conceptual design and manufacturing to the commercial distribution—of medical computing hardware and peripherals, primarily targeting the hospital and clinical IT markets within Taiwan. Their extensive product lineup encompasses a variety of advanced solutions, such as AI-enabled medical PCs and tablets, specialized computer and monitor setups for digital operating rooms and telemedicine, and adaptable medical cart computers. They also offer robust medical power panel PCs, power banks, and sophisticated battery management systems. Further offerings include portable medical tablets, professional slim and powerful all-in-one PCs, medical displays and integrated computing solutions for medical devices, as well as motherboards and industrial-grade PCs and tablets, alongside healthcare infotainment systems. In addition to their core products, Onyx Healthcare provides custom Original Design Manufacturing (ODM) and Original Equipment Manufacturing (OEM) services. Established in 2010, the company is headquartered in New Taipei City, Taiwan, and operates as a subsidiary of AAEON Technology Inc.
IPO date
Dec 21, 2016
Employees
Domiciled in
TW
Incorporated in
TW
Valuation
Title TWD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
| Income | |||||||
Revenues | |||||||
Cost of revenue | |||||||
Unusual Expense (Income) | |||||||
NOPBT | |||||||
NOPBT Margin | |||||||
Operating Taxes | |||||||
Tax Rate | |||||||
NOPAT | |||||||
Net income | |||||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | |||||||
BB yield | |||||||
| Debt | |||||||
Debt current | |||||||
Long-term debt | |||||||
Deferred revenue | |||||||
Other long-term liabilities | |||||||
Net debt | |||||||
| Cash flow | |||||||
Cash from operating activities | |||||||
CAPEX | |||||||
Cash from investing activities | |||||||
Cash from financing activities | |||||||
FCF | |||||||
| Balance | |||||||
Cash | |||||||
Long term investments | |||||||
Excess cash | |||||||
Stockholders' equity | |||||||
Invested Capital | |||||||
ROIC | |||||||
ROCE | |||||||
| EV | |||||||
Common stock shares outstanding | |||||||
Price | |||||||
Market cap | |||||||
EV | |||||||
EBITDA | |||||||
EV/EBITDA | |||||||
Interest | |||||||
Interest/NOPBT | |||||||